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ABSTRACT 
Purpose: The primary aim of this study was to examine the value of temperature as a diagnostic and 
prognostic indicator of infection and sepsis in neutropenic patients. A secondary aim was to gain 
insight into the presenting symptoms reported by these patients at home or on their initial 
admission assessment.   
Methods: A cohort study was carried out using a case note review of 220 emergency admissions to a 
regional cancer centre. All participants were neutropenic and were diagnosed with infection on 
admission. The main outcome measures were relationships between Early Warning Scores and 
temperature values at home, on admission and during the hospital stay.   
Results: 22% of patients who became acutely unwell did not have a fever. Pearson correlations 
showed only small associations between highest temperature value at any time point and highest 
early warning scores (r(202) =.176, P=.012). Temperature at home (B=.156, P=.336) and temperature 
on admission (B=.200, P=.052) did not predict highest Early Warning Scores.  
Conclusions: Body temperature is not a consistently reliable diagnostic or prognostic indicator for 
outcomes in patients with neutropenia and symptoms of infection. It can assist with early 
presentation and recognition of infection in many neutropenic patients. However, over-reliance on 
temperature risks missing the opportunity for early detection and treatment.   
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1. Introduction 
Sepsis is a life-threatening host response to infection that is a leading cause of mortality and critical 
illness (Singer et al., 2016). Prompt recognition, diagnosis and treatment are essential to improving 
outcomes with early signs of sepsis including increased respiration rate, hypotension and altered 
mental state (Singer et al., 2016; Shankar-Hari et al., 2016; National Institute for Health and Care 
Excellence (NICE), 2016). Patients who develop neutropenia due to systemic anti-cancer therapy, 
including chemotherapy, are at increased risk of developing sepsis as they are less able to marshal a 
response to infection. Early presentation to enable diagnosis and treatment has been identified as a 
priority for patient care but this can be challenged by diverse, often non-specific, presenting 
symptoms (Clarke et al., 2015; Wild, 2017) and a lack of evidence regarding their relationship to 
outcomes (NICE, 2012). 
A growing body of evidence suggests that infection in neutropenic patients is a heterogeneous 
condition with diverse outcomes (Tueffel et al., 2011; Klatersky et al., 2013). This has led to the 
introduction of risk stratified pathways to promote appropriate treatment, such as immediate 
interventions for patients with signs of sepsis, prompt intravenous antibiotics for those at higher risk 
of serious complications and measures to avoid unnecessary hospitalisation in those at lower risk 
(Lee et al., 2013; NCCN, 2017; Worth et al., 2011). Early detection of infection in neutropenic 
patients remains essential to facilitate appropriate treatment (Warnock, 2016) and evidence-based 
parameters are needed to support this process.  
A review of the evidence regarding the detection and management of neutropenic sepsis was 
carried out by the UK organisation, the National Institute for Health and Care Excellence (NICE, 
2012). The review concluded that most studies regarding neutropenic sepsis have included pyrexia 
among their diagnostic criteria and have excluded patients whose temperature values remain within 
normal limits (NICE, 2012). Pyrexia consistently features in the inclusion criteria for research studies 
(Carmona-Bayonas et al., 2011) in parameters for clinical guidance (de Naurois et al., 2010, NCCN 
2017) and evaluations of practice (Innes et al., 2008; Wierema et al., 2013).   However, recent 
reviews of the literature and UK cancer centre clinical guidelines have suggested that the role 
assigned to pyrexia in clinical practice regarding neutropenic sepsis is unclear (Clarke et al., 2011; 
NICE, 2012). The authors note that this can be seen in the range of different temperature values 
being used to denote a clinically significant fever which ranged from 37.50c to 38.50c. In addition, 
they found that the majority of clinical guidelines recommended suspecting neutropenic sepsis in 
patients receiving chemotherapy who were unwell even in the absence of a fever (Clarke et al., 
2011; NICE, 2012). A recent example of this approach is seen in the UK Oncology Nursing Society 
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triage tool which has been developed to support telephone advice services for patients receiving 
systemic anti-cancer therapy (SACT) (UKONS 2016). The tool is widely used in the UK and provides 
guidance to identify appropriate care pathways following an assessment of symptom severity. In the 
advice relating to patients with a fever, the trigger temperature to seek urgent assessment and 
medical review is 37.50c. However, the guidance also recommends that this same action should be 
taken by patients receiving SACT who feel generally unwell but do not have a raised temperature 
(UKONS, 2016). 
While questions have been raised about the clinical significance of particular temperature values 
there is a consensus that monitoring body temperature can play an important role in early detection 
(NICE, 2012). Many neutropenic patients with infection will have pyrexia as one of their symptoms 
and, for some, other presenting signs of infection may be reduced (Dunkley & Macleod, 2015). 
Neutropenia often occurs while the patient is at home, and self-monitoring of temperature to 
support early detection of infection by patients is recommended in local and national guidance (de 
Naurois et el., 2010). However, the lack of evidence regarding the clinical significance of 
temperature in neutropenic patients presents a challenge for patient education and clinical 
guidance. For example, what advice should healthcare staff give regarding trigger temperature 
values when they are providing patient information?  
The complex issues that can arise when providing patients with information regarding temperature 
monitoring have been highlighted by two separate qualitative studies that explored help-seeking 
experiences in patients with neutropenic sepsis (Clarke et al., 2015; Oakley et al., 2016). Both studies 
found that the emphasis placed on temperature values by healthcare professionals led to some 
patients delaying contacting the cancer centre until they had a temperature above 38oc even when 
they felt unwell. However, Clarke et al (2015) also found that advice regarding temperature values 
could facilitate early presentation, particularly in patients who were asymptomatic with symptoms 
of infection but detected a fever by self-monitoring their temperature at home (Clarke et al., 2015). 
Developing understanding of the relationships between temperature values, infection and outcomes 
in neutropenic patients may provide additional evidence to support patient information provision 
and clinical guidelines.  
The lack of clarity on the role of temperature in diagnosing infection and sepsis in neutropenia, along 
with a gap in the evidence relating to outcomes associated with different temperature values, 
presents a challenge to clinical practice. The need for further research on this topic has been 
identified (NICE, 2012). To address this the study reported here examined temperature recordings in 
adult solid tumour cancer patients admitted to a regional cancer centre with chemotherapy-induced 
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neutropenia. The primary aim of the research was to examine the value of temperature as a 
diagnostic and/or prognostic indicator of specific outcomes in neutropenic patients. A secondary aim 
was to gain insight into the presenting symptoms reported by patients at home or on their initial 
admission assessment.   
 
2. Methods 
A cohort study was carried out using case note reviews of patients admitted to a regional cancer 
centre in England, UK, who were neutropenic and were diagnosed with infection. The centre treats 
patients with solid tumours and does not provide high dose chemotherapy, stem cell transplant or 
haemato-oncology services. The cancer centre provides a 24 hour, 7 days a week telephone triage 
advice service for patients receiving cancer treatment and it directly admits the patients from across 
the region who are triaged as needing clinical review. Self-monitoring of temperature at home is 
advised to all patients receiving systemic anti-cancer therapy. The centre uses the UKONS triage tool 
(UKONS, 2016) and the trigger temperature for contacting the advice line is 37.5Oc. Patients are also 
ĂĚǀŝƐĞĚƚŽƌŝŶŐŝĨƚŚĞǇŚĂǀĞĂŶǇƐŝŐŶƐŽĨŝŶĨĞĐƚŝŽŶ ?ŝŶĐůƵĚŝŶŐĨĞĞůŝŶŐ “ŐĞŶĞƌĂůůǇƵŶǁĞůů ? ? 
Inclusion criteria for the study were all emergency non-elective admissions for treatment of 
neutropenic infection who attended the regional cancer centre for medical review. All patients were 
currently receiving chemotherapy treatment, neutropenic on admission (defined as a neutrophil 
count of 0.9 x109/L or less) and were diagnosed with actual or potential infection. Patients that met 
the inclusion criteria were identified from the record of non-elective admissions to the assessment 
unit and the inpatient wards at the cancer centre by the research team.  
The cancer centre covers a wide geographical area which contains five district general hospitals, 
each with an accident and emergency department. All patients are advised to contact the phone 
service at the cancer centre and in most situations are asked to attend the centre when triaged for 
clinical review. However, some patients do attend local services and the study sample did not 
include those who presented at their local accident and emergency department rather than 
contacting the phone advice line, or were admitted to their local district general hospital rather than 
the cancer centre. 
2.1 Study measures  
A proforma was designed to structure data collection which included demographic details along with 
cancer diagnosis, treatment data and the following measures.  
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2.1.1. Temperature  
Data collected regarding temperature included the value reported by the patient prior to admission 
(as recorded on the telephone triage form), the value on admission to the assessment unit, the 
highest value during admission and the total time temperature was 38oc or above during admission 
(from the first to the last reading at this level). 
2.1.2. Infection 
All patients had a diagnosis of infection documented in their care record. Signs and symptoms of 
infection were defined as any symptom of infection documented in the patient record, including 
non-specific symptoms, with or without elevated temperature. The broad sampling criteria aimed to 
include apyrexial patients as this population had previously been excluded from research into 
neutropenic sepsis (NICE, 2012). 
2.1.3 Early Warning Score 
The measure used to evaluate patient outcomes was their early warning score (EWS). EWS are a 
validated system for recording observations that are used to identify acutely unwell and 
deteriorating patients (Downey et al., 2017). EWS function by assigning scores to physiological 
parameters which are then combined to provide an aggregated score. Typically, a score of 0 is 
normal and scores increase to a maximum of 3 for each item as the levels deviate from the norm 
 ?ZW ? ? ? ? ? ?&ŽƌƚŚŝƐƐƚƵĚǇƚŚĞt^ǁĂƐĐĂůĐƵůĂƚĞĚĨƌŽŵƚŚĞĂŐŐƌĞŐĂƚĞƐĐŽƌĞƐĨŽƌƉĂƚŝĞŶƚ ?ƐďůŽŽĚ
pressure, pulse, respiration rate, oxygen saturations, level of consciousness and urine output. Body 
temperature is usually a component of an EWS but it was not included in the scores used in this 
study to enable comparison between EWS and temperature values. EWS systems in general (Corfield 
et al, 2014) and an aggregate score of 3 (Keep et al, 2016; Nutbeam et al, 2016) have been identified 
as sensitive measures for detecting deterioration and sepsis. An aggregate score of 3 or more was 
used to identify patients in our sample who were acutely unwell with potential signs of sepsis and 
those who scored 3 or higher on one or more occasion at or during their admission were labelled 
high EWS. Patients whose highest score was 2 or lower were labelled low EWS.  
2.1.4 Ethical approval 
Appropriate approvals for the study were received locally from the NHS Trust clinical effectiveness 
department and Cancer Centre research ethics committee and nationally from the NHS research 
ethics approval process.   
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2.2. Statistical analysis  
Data regarding demographic, diagnostic and treatment information were analysed from two 
perspectives: across all participants and separately within the high and low EWS groups. The 
association between temperature values and EWS were examined using chi-ƐƋƵĂƌĞĚ ?WĞĂƌƐŽŶ ?Ɛ
correlations and logistic regression tests. Data was analysed using SPSS 21.0.  
2.3. Study sample 
The cohort comprised of 220 patients admitted to a UK regional cancer centre for treatment of 
neutropenic infection between October 2013 and June 2015. To achieve the sample within the 
available data collection period, 110 patients were identified retrospectively and 110 patients 
prospectively (August 2014 to June 2015). However, the method of data collection, retrieval from 
documented patient records using a study proforma, was the same for both groups.  
 
3. Results  
3.1. Patient characteristics 
The initial sample of 220 patients was reviewed to remove individuals admitted on more than one 
occasion from the dataset to prevent double counting of factors that might influence outcomes, 
such as the risk of developing neutropenic sepsis. 18 such incidents were identified which produced 
a final sample of 202 patients, 99 sampled retrospectively and 103 prospectively. A series of 
independent samples t-tests were carried out to compare the retrospective and prospective samples 
using key study variables of age, highest EWS, temperature values at home, on admission, while in 
hospital and the highest temperature at any point. No significant differences were found between 
the two groups.  Chi-squared analysis showed that there was no difference in gender proportions 
between the retrospective and prospective samples. Subsequent analysis was therefore conducted 
using the combined samples.  
Demographic, diagnostic and performance status data is presented in table 1. 141 (69.8%) of the 
total sample were female. An independent samples t-test indicated that there was a significant 
difference between men (mean 2.246,SD 1.546) and women (mean 1.667,SD 1.602) on their highest 
EWS score (t(200)=2.384,P=.018). A Pearson correlation indicated no association between age and 
highest EWS (r(202)=.111,P=.117). There was wide variation in the number of patients with each 
cancer diagnosis precluding between diagnostic group comparisons. However, the highest incidence 
of patients with high EWS within a diagnostic group was found for small cell lung cancer (n=14, 
45.2%) followed by breast cancer (n=29, 33.3%).  
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3.2 Inclusion criteria characteristics.  
162 patients commenced intravenous antibiotics on admission while 40 were started on oral 
antibiotics (all 40 were in the low EWS group). 12 of these patients were subsequently changed to 
intravenous treatment due to a subsequent high temperature during admission although they 
remained in the low EWS group. The chemotherapy regimen patients had received and the number 
of days since their last treatment is detailed in table 1. There were 44 different regimens in total but 
seven accounted for 69% of the sample. 
 
168 (83.2%) patients had a neutrophil count of 0.5 x 109/L or less on admission, of which 59 (35%) 
were in the high EWS group. 34 (16.8%) patients had a neutrophil count between 0.6 and 0.9 x 109/L 
of which 9 (26.5%) were in the high EWS group. Pearson correlations examining the relationships 
between neutrophil count and highest EWS showed no significant association (r(202)=-.047,P=.508).  
 
3.3 Early warning score groups    
68 (34%) of the sample were in the high EWS group. The time period that patients had a high EWS 
varied: 24 (35.3%) had an EWS of 3 or more for one day, 37 (54.5%) for 2 to 4 days, 4 (5.9%) for 5 to 
7 days and 3 (4.4%) for 8 to 12 days.  
 
3.4 Presenting symptoms 
The symptoms reported to the telephone service and documented in the patient record on 
admission are listed in table 2. The most frequent symptoms were generalised and non-specific such 
ĂƐ “ĐŽůĚƐǇŵƉƚŽŵƐ ? ? ? ?ƉĂƚŝĞŶƚƐ ?39.1%), feeling generally unwell (46 patients, 22.8%) and flu-like 
symptoms (12 patients, 5.9%). 15 (7.4%) patients had an elevated temperature as their only 
documented presenting symptom, of which 7 were in the high EWS group.  
24 (35.3%) of the 68 patients in the high EWS group has a score of 3 or more at their initial 
admission assessment on arrival at the hospital; the remainder had presenting scores of 0 (8 
patients), 1 (27 patients) and 2 (9 patients). EWS on arrival did not differ between men and women 
(t(200)=.291,P=.771). 
3.5 Temperature and EWS   
The range, mean and standard deviation of temperature readings reported at home, recorded on 
admission and the highest values are detailed in table 3. The mean highest temperatures for both 
low and high EWS groups were above 38oc. Mean values on arrival at the hospital were lower than 
those at home and during admission.  
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Fig 1 shows temperature values at home, on admission and the highest during the hospital stay for 
low and high EWS groups. In the high EWS group the number of patients who did not have a 
temperature of 38oc or above was 44 (64.7%) on arrival, 23 (33.8%) during admission and 15 (22.1%) 
at any time point. The number of high EWS patients who did not have a temperature above 37.5oc 
was 32 on arrival, 9 during admission and 4 at any time point. Home temperature was documented 
for 52 of the high EWS patients. In this group 21 did not have a temperature above 380c when they 
rang the triage line and 6 did not have a temperature above 37.50c. The frequency of temperatures 
above and below 38oc at home and during admission in relation to high and low EWS groups is 
shown in table 4.  A chi-squared test showed no significant relationships between temperature 
category and EWS groups (ʖ2(3)=2.08, P=.555) and there was no partial association when gender was 
controlled.  
Pearson correlations examining the relationships between temperature values and highest EWS 
(table 5) showed only small associations between highest EWS and both highest temperature in 
hospital (r(202)=.165,P=.019) and highest temperature value at any time point, (r(202) =.176, 
P=.012). Temperature values on admission and at home were not associated with highest EWS. 143 
(70.8%) patients had a temperature of 38oc or above while in hospital. The number of hours 
between the first and last temperature reading on or above 38oc was calculated for these patients 
and no associations were found between duration of temperature of 38oc or above and highest EWS 
(r(143)=-.041,P=.635). There were no changes in significance when these analyses were repeated 
using partial correlations to control for gender.   
3.6 Temperature as a prognostic indicator.  
To examine whether temperature was a useful prognostic indicator of whether a patient would be in 
the high or low EWS group, a logistic regression analysis was conducted. Half degree categories of 
temperature (<37oc, 37oc-37.4oc, 37.5oc  W 37.9oc, 38oc - 38.4oc, 38.5oc  W 38.9oc, >39oc) at home and 
then on admission were used as categorical predictors of highest EWS, controlling for gender.  
Temperature at home (B=.156, P=.336) and temperature on admission (B=.200, P=.052) did not 
predict highest EWS. Temperature at home correctly classified only 67.5% of highest EWS cases, 
which included identifying only 13.5% of those who experienced an EWS of 3 or more. Temperature 
on admission correctly classified only 66.3% of highest EWS cases, which included identifying only 
11.8% of those who experienced an EWS of 3 or more.  
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4. Discussion  
This study presents new findings which show that body temperature is not a consistently reliable 
diagnostic or prognostic indicator in neutropenic patients with symptoms of infection. Elevated 
temperature was a symptom of infection for many, but not all, patients. There were no associations 
between temperature values at home or on admission with highest EWS, limiting the ability of 
temperature readings to predict whether a neutropenic patient might become acutely unwell 
because of infection.  A statistical model, predicting whether patients would be in the low or high 
EWS groups from half-degree temperature categories, correctly classified less than 14% of high EWS 
cases.  
4.1 The value of temperature monitoring by patients at home 
The findings from our study suggest that self-monitoring of temperature at home by patients 
contributes to the management of infection in neutropenia. Most patients had a temperature above 
37.5oc when they contacted the cancer centre and a smaller number had pyrexia as their only 
presenting feature including some in the high EWS group. While the study did not investigate 
whether temperature monitoring had been the trigger to action the high prevalence suggests it is 
possible that this was a factor. In addition, the value of self-monitoring was revealed by the pattern 
of temperature readings at different time points, specifically the mean temperature values on arrival 
at the hospital being lower than those reported at home and during the hospital stay.  
While the study found evidence of the positive potential of temperature monitoring it also identified 
a need for caution regarding over-reliance on temperature readings in patient advice and clinical 
decision making.  Several patients presented with home temperatures below the local trigger value 
of 37.5oc and this included some who developed high EWS during their admission. Our study 
suggests that patient information and clinical guidance should advise patients, their relatives and 
healthcare staff to observe for any signs of infection in patients who have or are at risk of 
neutropenia.  This includes generalised non-specific symptoms, which may or may not include an 
elevated temperature.  
4.2 Trigger temperature values  
Reviews of clinical guidance in UK cancer centres regarding neutropenic sepsis have noted a lack of 
consensus regarding trigger temperature values (Clarke et al, 2011). The authors noted that values 
ranging from 37.5oc to 38.5oc are used in different centres with some including additional criteria, 
such as 2 elevated readings one hour apart (Clarke et al, 2011). Our study identified patients who 
contacted ƚŚĞĐĂŶĐĞƌĐĞŶƚƌĞǁŝƚŚ “ĂƚŚŽŵĞ ?ƚĞŵƉĞƌĂƚƵƌĞƐďĞƚǁĞĞŶ ? ? ? ?oc and 37.9oc, including 
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some patients in the high EWS group. This finding suggests that a trigger temperature of 37.5oc may 
assist early detection in an increased number of patients and appears to support the advice provided 
in the UKONS triage tool guidance (UKONS, 2016) 
4.3 Presenting symptoms of infection and sepsis in neutropenic patients  
The NICE review on neutropenic sepsis reported that there was little research evidence available to 
support the identification of signs and symptoms that might predict neutropenic infection and sepsis 
in the community (NICE 2012). The current study identified a range of presenting symptoms that 
were described by patients when they contacted the phone line for advice or were documented in 
the initial admission assessment. However, most of the symptoms were non-specific such as feeling 
ŐĞŶĞƌĂůůǇƵŶǁĞůůŽƌŚĂǀŝŶŐ “ĐŽůĚ-ůŝŬĞ ?ƐǇŵƉƚŽŵƐ ?dŚŝƐǁĂƐƚŚĞĞƋƵĂůůǇƚŚĞĐase for patients who had 
uncomplicated infections and those who became acutely unwell. Similar findings were identified in a 
ƐƚƵĚǇŽĨƉĂƚŝĞŶƚ ?ƐĚĞƐĐƌŝƉƚŝŽŶƐŽĨƚŚĞŝƌƉƌĞƐĞŶƚŝŶŐƐǇŵƉƚŽŵƐ ?ůĂƌŬĞet al, 2015).  Based on the 
research evidence available at the time, the NICE review provided a broad recommendation that 
patients recently treated with chemotherapy who are unwell in the community should be urgently 
assessed in hospital (NICE 2012). The findings from the current study did not find any evidence of 
more specific predictive signs and symptoms.       
4.4 Temperature as a diagnostic marker in neutropenic sepsis 
Early and influential studies regarding neutropenic sepsis identified that pyrexia was a symptom of 
infection that alerted both patients and clinicians to the need for rapid assessment and treatment 
(Klatersky et al, 2013). This recognition lead to pyrexia, typically defined as a temperature of 38oc or 
above, being established as one of the inclusion criteria in much of the research and clinical 
evaluations of practice regarding infection-related outcomes in neutropenic patients.  Many of the 
patients in our study had a raised temperature that reached 38oc or more before or during their 
admission confirming pyrexia as a frequently occurring symptom of infection in this patient group.  
However, a sizeable number, including those with high EWS, did not have a temperature of 38oc at 
home or on initial assessment at the hospital and some remained apyrexial at all the study time 
points. This finding suggests that investigative studies regarding outcomes in neutropenia may 
benefit from widening their parameters to include those with temperature values within the normal 
range.  
The role of temperature as a diagnostic marker in sepsis has recently been evaluated by new 
international consensus guidance which aimed to differentiate between infection and sepsis (Singer 
et al., 2016). This guidance defines sepsis as a life-threatening body response to infection and 
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identifies physiological parameters such as increased respiration rate, hypotension and altered 
mental state as early signs (Singer et al., 2016; Shankar-Hari et al., 2016). Abnormal body 
temperature is described as a potential symptom of an infection-related cause, but its presence or 
absence is not included in the guidance as a diagnostic indicator of sepsis (Singer et al., 2016). In our 
study, pyrexia was not always present in patients who became acutely unwell due to infection. This  
finding indicates that this approach may also be appropriate in neutropenic patients.  
4.5 Strengths and limitations 
Strengths of this study are the broad inclusion criteria including patients with a diverse range of 
temperature values before, at and during admission as this group has not typically been explored in 
previous research. It is the first published study to provide data that supports the use of the 37.5oc 
temperature trigger contained in the UKONS triage tool. A potential limitation was the use of 
retrospective and prospective data. This approach was required to achieve the sample within 
funding and time constraints. The same methods of data collection were used throughout the study 
for both retrospective and prospective cases. Comparing the samples identified no significant 
differences between the two groups for the key variables and the data were sufficiently robust to 
answer the study questions.  
An additional limitation of the study is that a high number of patients in the sample were treated 
with intravenous antibiotics and did not develop signs of acute illness as indicated by raised EWS. It 
is not known how many of this group would have gone on to develop complications if they had not 
received early intervention or had received less intensive treatment with oral antibiotics. Any 
previous or future study would also be influenced by these factors to a degree as current guidance 
mandates anti-biotic treatment for all patients with neutropenic infection (Philips et al, 2012). The 
study sample was also limited in that it consisted of solid-tumour patients admitted to a regional 
cancer centre and did not include haemato-oncology patients or those who self-presented directly 
to their local accident and emergency departments.  
EWS were used in the study as the surrogate marker for signs of sepsis but other measures, such as 
lactate levels are sensitive predictors of outcomes in sepsis (Nutbeam et al, 2016; Junhasavasdikul et 
al, 2016). Their inclusion could add additional strength to this area of study. Lactate levels were not 
routinely monitored in the cancer centre during the study period so were not available.   
5. Conclusions 
Neutropenic sepsis is associated with substantial morbidity and mortality (Wierema et al, 2013). The 
non-specific nature of presenting symptoms, and inconsistency in the reliability of temperature as a 
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diagnostic and prognostic indicator, creates challenges for the assessment and detection of this 
condition. Tools are available that provide evidence-based criteria for identifying appropriate 
treatment pathways for neutropenic patients (Klatersky et al, 2013; Worth et al, 2011) and objective 
criteria for diagnosing sepsis and ongoing monitoring or patients at high risk (Nutbeam et al, 2016; 
NICE, 2016). The findings of this study reinforce the importance of monitoring for symptoms of 
infection, including pyrexia, but caution against over-reliance on temperature values. They suggest 
that broad-based inclusive criteria regarding symptoms and temperature values are required to 
promote early detection and initiation of appropriate treatment in this patient group. 
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 Table 1: Sample characteristics within the high and low Early Warning Score (EWS) categories  
 
 
All participants 
% (number) 
Low (EWS 2 or less) 
% (number) 
High (EWS 3 or more) 
% (number) 
Sample description 
Sample size 202 134 68 
Age (years)    
Range 17-87 17-83 20-87 
Mean  57.3 56.2 59.6 
Standard Deviation 13.079 12.522 13.931 
Gender    
Female 69.8% (141) 76.1% (102) 57.4% (39) 
Male 30.2% (61) 23.9% (32) 42.6% (29) 
Diagnosis    
Breast 43% (87) 43.2% (58) 42.6% (29) 
Small cell lung 15.3% (31) 12.7% (17) 20.6% (14) 
Head and neck  7.4% (15) 8.2% (11) 5.9% (4) 
Colorectal 6.4% (13) 7.5% (10) 4.4% (3) 
Non-small cell lung 5.9% (12) 7.5% (10) 2.9% (2) 
Sarcoma 4.5% (9) 5.2% (7) 2.9% (2) 
Upper GI 3.5% (7) 3.7% (5) 2.9% (2) 
Other  14% (28) 12% (16) 17.6% (12) 
Treatment details 
Chemotherapy regimen    
FEC 26.7% (54) 32.1% (43) 16.2% (11) 
Carboplatin Etoposide 15.3% (31) 12.7% (17) 20.6% (14) 
Docetaxol  7.9% (16) 4.5% (6) 14.7% (10) 
TAC 6.4% (13) 6.75% (9) 5.9% (4) 
Cyclophosphamide Docetaxol 5.9% (12) 6.75% (9) 4.4% (3) 
Docetaxol Cisplatin Fluorouracil 3.47% (7) 4.5% (6) 1.5% (1) 
Carboplatin Gemcitibine 3.47% (7) 5.2% (7) 0 
Irinotecan and Fluorouracil 3% (6) 2.2% (3) 4.4% (3) 
Cisplatin (single agent) 3% (6) 2.2% (3) 4.4% (3) 
Carboplatin Paclitaxel 3% (6) 2.2% (3) 4.4% (3) 
Other  regimens  21.8% (44) 63.6% (28) 36.4% (16) 
Days since chemotherapy     
0-4 1.5% (3) 1.5% (2) 1.5% (1) 
5-9 25.2% (51) 26.1% (35) 23.5% (16) 
10-14 47% (95) 45.5% (61) 50% (34) 
15-20 23.8% (48) 23.1% (31) 25% (17) 
21-25 2.5% (5) 3.7% (5) 0 
 
Abbreviations  
FEC - Fluorouracil Epirubicin Cyclophosphamide 
TAC - Doxorubicin Docetaxol  cyclophosphamide 
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Table 2: Presenting symptoms for all participants and within high and low Early Warning Score 
(EWS) groups  
Presenting symptoms All participants Low EWS (2 or less) High EWS (3 or more) 
Symptoms described as a cold 79 (39.1%) 54 (40.3%) 25 (36.8%) 
 “'ĞŶĞƌĂůůǇƵŶǁĞůů ? 46 (22.8%) 29 (21.6%) 17 (25%) 
Diarrhoea 35 (17.3%) 24 (17.9%) 11 (16.2%) 
Sore mouth 29 (14.4%) 24 (17.9%) 5 (7.4%) 
Nausea and vomiting  29 (14.4%) 18 (13.4%) 11 (16.2%) 
Breathlessness 20 (9.9%) 11 (8.2%) 9 (13.2%) 
Pyrexia only 15 (7.4%) 8 (6%) 7 (10.3%) 
Flu symptoms 12 (5.9%) 8 (6%) 4 (5.9%) 
Green sputum 12 (5.9%) 7 (5.2%) 5 (7.4%) 
Urinary symptoms 8 (4%) 4 (3%) 4 (5.9%) 
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Table 3: Temperature values (0C) at home, on arrival and highest during admission and at all time points by low and high Early Warning Score 
groups 
Temperature 
values 
Low Early Warning Score (2 or less) 
 
High Early Warning Score (3 or more) 
 Number Range (oC) Median (oC) Mean (oC) SD Number Range (oC) Median (oC) Mean (oC) SD 
At home  99 35.3 to 40.0 38.0 37.98 .593 52 36.4 to 39.2 38.0 38.12 .672 
On arrival 134 35.5 to 39.2 37.35 37.34 .770 68 35.5 to 39.2 37.60 37.58 .906 
Highest during stay  134 36.5 to 40.6 38.0 38.06 .755 68 36.9 to 40.5 38.25 38.28 .737 
Highest overall 134 36.6 to 40.6 38.20 38.24 .713 68 36.9 to 40.5 38.50 
 
38.48 .673 
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Figure 1. (A) Temperature values reported by participants prior to admission in relation to high and 
low Early Warning Score (EWS) group. (B) Temperature values recorded on admission in relation to 
high and low Early Warning Score (EWS) group. (C) Highest temperature values recorded during 
admission in relation to high and low Early Warning Score (EWS) group  
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Table 4: The frequency of temperature values reported prior to admission and then during hospital 
admission for low and high Early Warning Score (EWS) groups*  
 Low EWS  
(2 or less) 
High EWS 
(3 or more) 
Total 
 
Above or equal to 380c at home and during 
admission 
38 23 61 
 
Above or equal to 380c at home, not above or equal 
to 380c during admission 
20 8 28 
 
Less than 380c at home, above or equal to 380c 
during admission   
17 12 29 
 
Less than 380c at home and during admission  24 9 33 
 
*Pre-admission temperature values available for 151 patients (99 low EWS, 52 high EWS) 
 
 
 
 
 
 
Table 5: Pearson correlations between temperature values and highest Early Warning Scores (EWS)   
 Highest EWS Temp at home Temp on 
admission 
Highest temp in 
hospital 
Temp at home            .017 P=.837 
 
   
Temp on admission .127 P=.071 .139 P=.089 
 
  
Highest in hospital .165 P= .019 .293 P=.000 .529 P=.000  
 
Highest temp  
(home or hospital)  
 
.176 P=.012 
 
.616 P=.000 
 
.432 P=.000 
 
.862 P=.000 
All calculated from 202 participants with the exception of temperature at home (n=151). 
Significance values did not change when using partial correlations for highest EWS controlling for 
gender.  
 
 
 
 
 
 
